Literature DB >> 22825317

Mutations in the sarcosine dehydrogenase gene in patients with sarcosinemia.

Ifat Bar-joseph1, Elon Pras, Haike Reznik-Wolf, Dina Marek-Yagel, Almogit Abu-Horvitz, Maya Dushnitzky, Nurit Goldstein, Shlomit Rienstein, Michal Dekel, Ben Pode-Shakked, Joseph Zlotnik, Anelia Benarrosh, Philippe Gillery, Niklaus Hofliger, Christiane Auray-Blais, Roselyne Garnotel, Yair Anikster.   

Abstract

Sarcosinemia is an autosomal recessive metabolic trait manifested by relatively high concentrations of sarcosine in blood and urine. Sarcosine is a key intermediate in 1-carbon metabolism and under normal circumstances is converted to glycine by the enzyme sarcosine dehydrogenase. We encountered six families from two different descents (French and Arab), each with at least one individual with elevated levels of sarcosine in blood and urine. Using the "candidate gene approach" we sequenced the gene encoding sarcosine dehydrogenase (SARDH), which plays an important role in the conversion of sarcosine to glycine, and found four different mutations (P287L, V71F, R723X, R514X) in three patients. In an additional patient, we found a uniparental disomy in the region of SARDH gene. In two other patients, we did not find any mutations in this gene. We have shown for the first time that mutations in the SARDH gene are associated with sarcosinemia. In addition, our results indicate that other genes are most probably involved in the pathogenesis of this condition.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22825317     DOI: 10.1007/s00439-012-1207-x

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  18 in total

1.  Complete cytogenetic investigation of oocytes from a young cancer patient with the use of comparative genomic hybridisation reveals meiotic errors.

Authors:  Elpida Fragouli; Dagan Wells; Alpesh Doshi; Sarah Gotts; Joyce C Harper; Joy D A Delhanty
Journal:  Prenat Diagn       Date:  2006-01       Impact factor: 3.050

2.  Sarcosinaemia in a patient with severe progressive neurological damage and hypertrophic cardiomyopathy.

Authors:  T Meissner; E Mayatepek
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

3.  Maternal isodisomy for chromosome 9 causing homozygosity for a novel FOXE1 mutation in syndromic congenital hypothyroidism.

Authors:  Mireille Castanet; Uma Mallya; Maura Agostini; Erik Schoenmakers; Catherine Mitchell; Stephanie Demuth; F Lucy Raymond; John Schwabe; Mark Gurnell; V Krishna Chatterjee
Journal:  J Clin Endocrinol Metab       Date:  2010-05-19       Impact factor: 5.958

4.  Clinical and cellular studies of sarcosinemia.

Authors:  C R Scott; S H Clark; C C Teng; K R Swedberg
Journal:  J Pediatr       Date:  1970-11       Impact factor: 4.406

5.  Labile methyl group balances in the human: the role of sarcosine.

Authors:  S H Mudd; M H Ebert; C R Scriver
Journal:  Metabolism       Date:  1980-08       Impact factor: 8.694

6.  Identification of folate binding protein of mitochondria as dimethylglycine dehydrogenase.

Authors:  A J Wittwer; C Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

7.  Hypersarcosinemia: an inborn error of metabolism.

Authors:  T Gerritsen; H A Waisman
Journal:  N Engl J Med       Date:  1966-07-14       Impact factor: 91.245

8.  Desmoglein 4 in hair follicle differentiation and epidermal adhesion: evidence from inherited hypotrichosis and acquired pemphigus vulgaris.

Authors:  Ana Kljuic; Hisham Bazzi; John P Sundberg; Amalia Martinez-Mir; Ryan O'Shaughnessy; My G Mahoney; Moise Levy; Xavier Montagutelli; Wasim Ahmad; Vincent M Aita; Derek Gordon; Jouni Uitto; David Whiting; Jurg Ott; Stuart Fischer; T Conrad Gilliam; Colin A B Jahoda; Rebecca J Morris; Andrei A Panteleyev; Vu Thuong Nguyen; Angela M Christiano
Journal:  Cell       Date:  2003-04-18       Impact factor: 41.582

9.  sar: a genetic mouse model for human sarcosinemia generated by ethylnitrosourea mutagenesis.

Authors:  C O Harding; P Williams; D M Pflanzer; R E Colwell; P W Lyne; J A Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

10.  Newborn urine screening experience with over one million infants in the Quebec Network of Genetic Medicine.

Authors:  B Lemieux; C Auray-Blais; R Giguère; D Shapcott; C R Scriver
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

View more
  5 in total

1.  A young adult with sarcosinemia. No benefit from long duration treatment with memantine.

Authors:  A Benarrosh; R Garnotel; A Henry; C Arndt; P Gillery; J Motte; S Bakchine
Journal:  JIMD Rep       Date:  2012-10-21

2.  Chemically induced acute model of sarcosinemia in wistar rats.

Authors:  Rodrigo Binkowski de Andrade; Tanise Gemelli; Denise Bertin Rojas; Carlos Severo Dutra-Filho; Clovis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2015-11-12       Impact factor: 3.584

Review 3.  Sarcosine as a potential prostate cancer biomarker--a review.

Authors:  Natalia Cernei; Zbynek Heger; Jaromir Gumulec; Ondrej Zitka; Michal Masarik; Petr Babula; Tomas Eckschlager; Marie Stiborova; Rene Kizek; Vojtech Adam
Journal:  Int J Mol Sci       Date:  2013-07-04       Impact factor: 5.923

4.  A Rapid Method for the Detection of Sarcosine Using SPIONs/Au/CS/SOX/NPs for Prostate Cancer Sensing.

Authors:  Dagmar Uhlirova; Martina Stankova; Michaela Docekalova; Bozena Hosnedlova; Marta Kepinska; Branislav Ruttkay-Nedecky; Josef Ruzicka; Carlos Fernandez; Halina Milnerowicz; Rene Kizek
Journal:  Int J Mol Sci       Date:  2018-11-22       Impact factor: 5.923

Review 5.  Mitochondrial transport and metabolism of the vitamin B-derived cofactors thiamine pyrophosphate, coenzyme A, FAD and NAD+ , and related diseases: A review.

Authors:  Ferdinando Palmieri; Magnus Monné; Giuseppe Fiermonte; Luigi Palmieri
Journal:  IUBMB Life       Date:  2022-03-18       Impact factor: 4.709

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.